Industry group suspends drug company for breaching codeBMJ 2006; 333 doi: https://doi.org/10.1136/bmj.333.7571.717-a (Published 05 October 2006) Cite this as: BMJ 2006;333:717
- Owen Dyer
Merck Sharp & Dohme UK (MSD) has been suspended from the Association of the British Pharmaceutical Industry for offering a blood pressure testing service only to doctors who prescribed the company's hypertension drug losartan (Cozaar).
The company, the British subsidiary of Merck, was found to have committed serious breaches of the industry watchdog's code of practice. Clause 2 of …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial